have been introduced as core centre in liquid crystalline compounds. In this paper, we report the synthesis of a new Schiff base comprising the benzothiazole moiety: 4-[(1,3-benzothiazol-2-ylimino)methyl]phenyl dodecanoate. This new compound exhibits enantiotropic smectic A phase, as indicated by thermal (DSC) and polarizing optical microscopy studies.
Schiff bases have attracted much attention ever since the discovery of the first room temperature liquid crystal, 4-methoxybenzylidene-4'-butylaniline [1] . Many kinds of heterocyclic structures, such as pyridine [2] , furan [3] , thiophene [4] and benzothiazole [5] [6] [7] have been introduced as core centre in liquid crystalline compounds. In this paper, we report the synthesis of a new Schiff base comprising the benzothiazole moiety: 4-[(1,3-benzothiazol-2-ylimino)methyl]phenyl dodecanoate. This new compound exhibits enantiotropic smectic A phase, as indicated by thermal (DSC) and polarizing optical microscopy studies.
In analogy to a recently published procedure [8] , a solution of 2-aminobenzothiazole (6.01 g, 40 mmol) and 4-hydroxybenzaldehyde (4.88 g, 40 mmol) in absolute ethanol (60 mL) was heated under reflux for 3 h. The solvent was removed by slow evaporation and Schiff base 1 thus obtained was recrystallized from absolute ethanol. Then, Schiff base 1 (5.09 g, 20 mmol) in dimethylformamide (10 mL), was added to a solution of dodecanoic acid (4.01 g, 20 mmol) and 4-dimethylaminopyridine added dropwise while stirring in the ice bath for 1 h. The resulting mixture was subsequently stirred at room temperature for another 3 h. Then, the reaction mixture was filtered and the excess solvent was removed from the filtrate by evaporation. Recrystallization from absolute ethanol gave the Schiff base 2 as yellow solid (44%). 
